Dallas, TX -- October 1, 2015 -- InvestorsHub NewsWire -- North
American Cannabis Holdings, Inc. (USMJ)
and Puration, Inc. (PURA)
today announced the first production run of the EpiVape product.
EpiVape is a cost effective disposable hemp oil medicinal
vaporizer. The unique shape is not only functional but also
intended to set the Epivape product apart from the currently
available cigarette shaped vaporizers in an appeal to the medicinal
user rather than the recreational user.
Dr. Sanjay Gupta, Chief Medical
Correspondent from CNN, has publicly supported hemp oil and the
Cannabidiol, or CBD, in hemp oil as a real solution to epileptic
seizures and muscle spasms. In addition to its use in the treatment
of epilepsy, and muscle spasms caused from MS and Parkinsons, CBD
oil is being used to treat symptoms and other neurological
disorders. CBD enters the blood stream more quickly through
vaporizing than through other ingestion methods.
North American Cannabis Holdings entered into an agreement in
November of 2014 to partner with World Hemp Oil to bring the
EpiVape product to market. Today the company has finalized on a
production design and selected a manufacturer. The EpiVape product
is expected to be available for online and retail sales in the
first quarter of 2016. North American Cannabis Holdings, Puration
and World Hemp are pushing to have online sales possibly ready by
year end.
USMJ and PURA Cannabis Consumer Health Product Spin-off and
Dividend
North American Cannabis Holdings
recently entered into an agreement to move its cannabis consumer
health product operations under Puration, Inc. North American
Cannabis Holdings exchanged its cannabis consumer health product
operations for preferred stock of Puration. A portion of the
Puration preferred stock is slatted for conversion into Puration
common stock to be distributed to North American Cannabis Holdings
shareholders through a dividend distribution.
North American Cannabis Holdings and Puration plan to have the
dividend process detailed in the upcoming North American Cannabis
Holdings annual report due out within the next 15 days. The
issuance of Puration common stock to North American Cannabis
Holdings shareholders requires a number of steps to include the
update of Purations financial reporting.
The AmeriCanna Caf and Flagship CityBlends Caf Acquisition
Over the last two years, North American Cannabis Holdings has
been developing a variety of cannabis consumer product lines
through enterprise pilot projects. Recently, the Company announced
the acquisition of the CityBlends Caf
flagship retail store as the cornerstone in a strategy to
rollout a national AmeriCanna Caf chain serving cannabis infused
beverages. The first AmeriCanna Caf site has been
selected with plan to open for business in the summer of 2016.
The Company recently attracted media attention when it introduced
its first hemp infused smoothies at the recently acquired
CityBlends Caf.
NBC EVENING NEWS FEATURES AMERICANNA
CAFE
DALLAS MORNING NEWS ARTICLE ON
AMERICANNA CAF EVENT AT CITYBLENDS
SETH ROGEN AND JAMES FRANCO CLIP
FROM PINEAPPLE EXPRESS INTRODUCE USMJ CANNABIS SMOOTHIE
HOUSTON CHRONICLE FEATURES
AMERICANNA CAF
Ongoing Cannabis Consumer Product Development And Future
Spin-offs
The company plans to maintain the AmeriCanna Caf in house but
otherwise spinoff future enterprise cannabis consumer product
pilots ready for production in transactions similar to the recent
Puration transaction.
About North American Cannabis Holdings, Inc.
North American Cannabis Holdings, Inc. (USMJ)
is founded on the core belief that cannabis makes people's lives
better. Cannabis can fight disease, improve wellness and do so in
an environmentally sustainable manner. North American Cannabis
Holdings is dedicated to finding the best possible applications for
cannabis to serve consumers. For more information please
visit www.growusmj.com.
Caprock Research Report On North American Cannabis
Holdings
Follow the company on Twitter: http://twitter.com/US_HEMP.
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), and as such, may involve risks and
uncertainties. These forward looking statements relate to, amongst
other things, current expectation of the business environment in
which the company operates, potential future performance,
projections of future performance and the perceived opportunities
in the market. The company's actual performance, results and
achievements may differ materially from the expressed or implied in
such forward-looking statements as a result of a wide range of
factors.
CONTACT:
Phone: +1-972-528-0162
Email: Info@growusmj.com